Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
- PMID: 17083760
Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
Abstract
Remission is now the accepted goal of management in rheumatoid arthritis (RA). This article highlights the controversies surrounding the definition of remission and reviews the potential of current treatment options to achieve remission. Defining "true" remission can be difficult based on current criteria, which do not consider structural and physical function. Nonetheless, considerable advances in recent years have made the concept of remission a realistic goal. In early RA, substantial and largely irreversible radiographic damage is seen in 60% of patients within the first 2 years of diagnosis. Early therapeutic intervention would ideally lead to reduction in long-term disability in RA and likelihood of inducing and maintaining remission.Long-term maintenance therapy with disease-modifying antirheumatic drugs (DMARDs) has been shown to be effective in preventing flares of disease. Stopping therapy for short periods does not necessarily lead to flares, but the effect on long-term radiographic damage and potential to achieve similar levels of disease control following reinstatement of therapy is not established. Early use of tumour necrosis factor (TNF)-antagonist therapy (e.g. infliximab) has been shown to lead to significant improvement in disease activity measures (clinical and radiologic outcomes) when compared to monotherapy or combination DMARD and corticosteroid therapies. Response was shown to be sustained in 70% of patients receiving TNF-blocking therapy 1 year after stopping treatment. This suggests the significant role of TNF-blocking therapy in enabling sustainable remission without need for long-term administrations, which has important implications for favourable health economics. At present, little published evidence exists on the effects of withdrawal of TNF-blocking therapy in patients with established RA in remission. In conclusion, evidence indicates that remission is a realistic goal, but more evidence is required to establish optimal treatment strategies and define criteria for remission that include imaging and immunological as well as clinical assessment of the disease state.
Similar articles
-
Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis.Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii15-ii22. doi: 10.1093/rheumatology/kew352. Rheumatology (Oxford). 2016. PMID: 27856656 Review.
-
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420. Health Technol Assess. 2006. PMID: 17049139 Review.
-
Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S4-8. Epub 2013 Oct 3. Clin Exp Rheumatol. 2013. PMID: 24129128 Review.
-
Current concepts in the management of rheumatoid arthritis.Korean J Intern Med. 2016 Mar;31(2):210-8. doi: 10.3904/kjim.2015.137. Epub 2016 Feb 26. Korean J Intern Med. 2016. PMID: 26932398 Free PMC article. Review.
-
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.Cochrane Database Syst Rev. 2014 Sep 29;(9):CD010455. doi: 10.1002/14651858.CD010455.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 May 24;5:CD010455. doi: 10.1002/14651858.CD010455.pub3. PMID: 25264908 Updated. Review.
Cited by
-
Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review.Healthcare (Basel). 2021 Dec 13;9(12):1726. doi: 10.3390/healthcare9121726. Healthcare (Basel). 2021. PMID: 34946453 Free PMC article. Review.
-
Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.Biomed Res Int. 2018 Sep 9;2018:3878953. doi: 10.1155/2018/3878953. eCollection 2018. Biomed Res Int. 2018. PMID: 30271781 Free PMC article.
-
Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Am J Transl Res. 2017 Aug 15;9(8):3758-3775. eCollection 2017. Am J Transl Res. 2017. PMID: 28861167 Free PMC article.
-
Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis.PLoS One. 2016 Sep 7;11(9):e0161727. doi: 10.1371/journal.pone.0161727. eCollection 2016. PLoS One. 2016. PMID: 27603313 Free PMC article.
-
Ultrasound-detected subclinical inflammation was better reflected by the disease activity score (DAS-28) in patients with suspicion of inflammatory arthritis compared to established rheumatoid arthritis.Clin Rheumatol. 2016 Oct;35(10):2411-9. doi: 10.1007/s10067-016-3326-6. Epub 2016 Jun 21. Clin Rheumatol. 2016. PMID: 27325125 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical